RYVLX | UTPSX | RYVLX / UTPSX | |
Total Expense Ratio | 1.90 | 2.78 | 68% |
Annual Report Gross Expense Ratio | 2.01 | 2.84 | 71% |
Fund Existence | 21 years | 25 years | - |
Gain YTD | -16.290 | 7.953 | -205% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 15000 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 778M | 13.9M | 5,597% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 0.69 | 21.48 | 3% |
Returns for 3 years | 65.65 | 10.98 | 598% |
Returns for 5 years | 137.90 | 61.34 | 225% |
Returns for 10 years | 490.74 | 129.34 | 379% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RREYX | 29.65 | 0.02 | +0.07% |
Russell Inv Global Real Estate Secs Y | |||
LGSCX | 11.33 | N/A | N/A |
Franklin U.S. Small Cap Equity FI | |||
ETIHX | 30.51 | N/A | N/A |
Eventide Healthcare & Life Sciences I | |||
OSMCX | 33.60 | N/A | N/A |
Invesco International Small-Mid Com C | |||
VIEIX | 131.68 | N/A | N/A |
Vanguard Extended Market Index Instl |